Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension
Overview
Authors
Affiliations
[Figure: see text].
Myint N Cureus. 2025; 16(12):e75153.
PMID: 39759607 PMC: 11699854. DOI: 10.7759/cureus.75153.
Oral blood pressure augmenting agents for intravenous vasopressor weaning.
Robinson J, ElSaban M, Smischney N, Wieruszewski P World J Clin Cases. 2024; 12(36):6892-6904.
PMID: 39726934 PMC: 11531983. DOI: 10.12998/wjcc.v12.i36.6892.
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).
Khalil I, Sayad R, Kedwany A, Sayed H, Caprara A, Rissardo J Med Int (Lond). 2024; 4(6):70.
PMID: 39355336 PMC: 11443310. DOI: 10.3892/mi.2024.194.
Mwesigwa N, Millar Vernetti P, Kirabo A, Black B, Ding T, Martinez J Clin Auton Res. 2024; 34(6):561-569.
PMID: 39294522 PMC: 11543771. DOI: 10.1007/s10286-024-01051-2.
Mast cell activation syndrome: An up-to-date review of literature.
Ozdemir O, Kasimoglu G, Bak A, Sutluoglu H, Savasan S World J Clin Pediatr. 2024; 13(2):92813.
PMID: 38948000 PMC: 11212760. DOI: 10.5409/wjcp.v13.i2.92813.